Page 7 - Activating Construct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Activating construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Activating Construct Today - Breaking & Trending Today

Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie

Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Julie Eastland , Roberth Uhl , Exchange Commission , European Society For Mdical Oncology , Harpoon Therapeutics Inc , International Myeloma Society , Therapeutics Provides , Option Agreement , Annual Meeting , European Society , Mdical Oncology , Activating Construct , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic ,

Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting

Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sumit Madan , Roberth Uhl , International Myeloma Society , Exchange Commission , Banner Md Anderson Cancer Center , International Myeloma Society Annual Meeting , Harpoon Therapeutics Inc , Therapeutics Abstract , Poster Presentation , International Myeloma Society Annual , Annual Meeting , Ongoing Phase , Targetingb Cell Maturation Antigen , Refractory Multiple Myeloma , Poster Session , Trianti Hall Level , Activating Construct , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic ,

Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023

KOLs to provide insight and discussion of HPN328 targeting SCLC, NEPC and other neuroendocrine tumors Abstract with HPN328 interim data accepted for poster presentation at the European Society for. ....

Erin Schenk , Maria Yonkoski , Himisha Beltran , Roberth Uhl , Division Of Medical Oncology , European Society For Medical Oncology , University Of Colorado Anschutz Medical Campus , Harpoon Therapeutics Inc , Harvard Medical School , Dana Faber Cancer Institute , Exchange Commission , European Society , Medical Oncology , New York , Associate Professor , Harvard Medical , Assistant Professor , Colorado Anschutz Medical , Investor Relations , Activating Construct , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic ,

Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society Annual Meeting and the European Society for Medical Oncology in the fall Enrollment for HPN328 . ....

Julie Eastland , Haibo Wang , Roberth Uhl , International Myeloma Society , Harpoon Therapeutics Inc , Business Development At Amgen , Abbvie Restated Research , Harpoon Development Option Agreement , Exchange Commission , European Society For Medical Oncology , Business Development , Business Development At Hummingbird Bioscience , Annual Meeting , European Society , Medical Oncology , Harpoon Therapeutics , Recent Highlights , Activating Construct , Senior Vice President , Vice President , Five Prime Therapeutics , Development Option Agreement , Discovery Collaboration Agreement , Private Securities Litigation Reform Act , Harpoon Therapeutic , Comprehensive Income ,

Harpoon Therapeutics appoints Haibo Wang as SVP of business development

Wang, who joins Harpoon from Hummingbird Bioscience, has a background of 15 years in biopharma business development and finance. ....

Haibo Wang , Julie Eastland , Luke Walker , Harpoon Therapeutics , Hummingbird Bioscience , Five Prime , Activating Construct ,